More FDA criticises Supplier Qualification in Warning Letter
More Inspection of biotechnological Manufacturers - PIC/S AiM Updated
More FDA stops Hand Sanitizers with too low Alcohol Content at the US Border
More UK Guidance on Limits for Controlled Cannabinoids in CBD Products
More 25 Years Alternative Pyrogen Testing: Where do we stand? A Retrospect and Outlook
More EMA Clarifies GMP Requirements for Herbal Substances Used as APIs
More FDA Applications during Covid-19: better Communication planned
More Updated Guidance on the Management of Clinical Trials during COVID-19
More Insufficient Quality System leads to GDP Non-Compliance Report
More FDA Plans for new (GMP) Guidance in 2021 - CDER provides Information
More Questions & Answers on Good Distribution Practices (GDP) - Part 1